USE OF PROSTAGLANDINES FOR PRODUCING A MEDICINAL PRODUCT FOR PREVENTING AND TREATING THE SECONDARY CATARACT

摘要

PCT No. PCT/SE95/01058 Sec. 371 Date May 12, 1997 Sec. 102(e) Date May 12, 1997 PCT Filed Sep. 19, 1995 PCT Pub. No. WO96/09054 PCT Pub. Date Mar. 28, 1996The present invention relates to a method for treatment or prevention of secondary cataract, comprising contacting the surface of the eye with an effective amount of a therapeutically active and physiologically acceptable prostaglandin comprising a prostaglandin A, a prostaglandin J, a derivative of prostaglandin A or a derivative of prostaglandin J.